UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
September 16, 2004
ENCORE MEDICAL CORPORATION
(Exact name of registrant as specified in charter)
| | | | | |
Delaware
(State or other jurisdiction of
incorporation or organization) | | 000-26538
(Commission File Number) | | 65-0572565
(IRS Employer
Identification No.) |
9800 Metric Blvd.
Austin, Texas 78758
(Address of principal executive offices and zip code)
(512) 832-9500
(Registrant’s telephone
number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425). |
| |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12). |
| |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). |
| |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)). |
TABLE OF CONTENTS
Item 8.01 Other Events.
On September 16, 2004, Encore Medical Corporation announced that it intends to commence a private placement offering of $165 million of senior subordinated notes due 2012 to be issued by a wholly owned subsidiary. The notes will be unsecured and guaranteed by Encore and the issuer’s domestic subsidiaries. A copy of the press release announcing the offering is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
| | | |
| Exhibit 99.1 – | | Press release dated September 16, 2004 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | ENCORE MEDICAL CORPORATION
| |
| Date: September 16, 2004 | By: | /s/ Harry L. Zimmerman | |
| | | Harry L. Zimmerman | |
| | | Executive Vice President -- General Counsel | |
| |
3
Exhibit Index
| | | |
Exhibit No.
| | Description
|
| 99.1 | | Press release dated September 16, 2004 |
4
